Sun Pharmaceutical Industries board to approve unaudited financial results

04 Jan 2021 Evaluate

Sun Pharmaceutical Industries has informed that the meeting of the Board of Directors of the Company will be held on Friday, January 29, 2021 to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2020. Further, pursuant to the Company’s Code of Conduct for Prevention of Insider Trading, the window closure for trading by Designated Persons, commenced on January 01, 2021, and shall end on January 31, 2021 i.e. after 48 hours of the declaration of financial results of the Company on January 29, 2021.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1786.05 -40.05 (-2.19%)
10-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.05
Dr. Reddys Lab 1354.20
Cipla 1470.05
Lupin 2190.50
Zydus Lifesciences 1004.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.